Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
European Low and Intermediate Risk Neuroblastoma – A SIOPEN Study
Protocol ID
LINES
Disease (Sub Disease)
Solid tumours(Neuroblastoma)
Diagnosis Stage
New diagnosis
Location
NSW, VIC, WA
Sponsor
Instituto de Investigacion Sanitaria La Fe
Trial Status
Open
Sites
John Hunter Children's Hospital
Monash Children's Hospital
Sydney Children's Hospital
Perth Children's Hospital
Study Type
Treatment
Phase
Phase 3
Age Eligibility
90 days to 18 Years
International registry ID's
NCT01728155
Back to Registry
Study Title European Low and Intermediate Risk Neuroblastoma – A SIOPEN Study
Protocol ID LINES
Disease (Sub Disease) Solid tumours(Neuroblastoma)
Diagnosis Stage New diagnosis
Location NSW / VIC / WA
Sponsor Instituto de Investigacion Sanitaria La Fe
Links https://clinicaltrials.gov/ct2/show/NCT01728155
Trial Status Open
Trial Open Date 31/05/2019
Sites John Hunter Children's Hospital / Monash Children's Hospital / Sydney Children's Hospital / Perth Children's Hospital
Study Type Treatment
Phase Phase 3
Age Eligibility 90 days to 18 Years
International registry ID's NCT01728155